1. George D Yancopoulos was born on 1959 and is a Greek-American biomedical scientist who is the co-founder, president and chief scientific officer of Regeneron Pharmaceuticals.
17 Facts About George Yancopoulos
1. 2.
George Yancopoulos is a principal inventor and developer of Regeneron's ten FDA-approved or -authorized treatments, as well as of Regeneron's foundational technologies for target and drug development, such as its proprietary TRAP technology, and the VelociGene and VelocImmune antibody technologies.
3.
George Yancopoulos is the son of Greek immigrants, and spent his early childhood in Woodside, New York.
4.
George Yancopoulos then worked in the field of molecular immunology at Columbia University with Dr Fred Alt, for which he received the Lucille P Markey Scholar Award.
5.
George Yancopoulos was elected to both the National Academy of Sciences and the American Association for the Advancement of Science in 2004.
6.
George Yancopoulos was a graduate student in Fred Alt's laboratory at Columbia University in the 1980s.
7.
George Yancopoulos's work has included study of how nerves regenerate and how muscles connect to nerves.
8.
George Yancopoulos's group cloned receptors for neurotrophic factors, such as TrkB, the receptor for BDNF, and showed that they were sufficient to mediate signaling without the requirement of the Low affinity Nerve Growth Factor receptor.
9.
George Yancopoulos was the first to propose making mouse models with genetically human immune systems.
10.
George Yancopoulos plays an active role in Regeneron's STEM Education commitments, including the Regeneron Science Talent Search, America's oldest high school science and math competition.
11.
George Yancopoulos is the first research and development chief in the pharmaceutical industry to become a billionaire.
12.
George Yancopoulos has been awarded Columbia University's Stevens Triennial Prize for Research and its University Medal of Excellence for Distinguished Achievement.
13.
George Yancopoulos was inducted into the Bronx Science Hall of Fame in 2017 and was recognized by the Yale School of Management, CEO Institute as a Legends in Leadership Award in 2017.
14.
George Yancopoulos was recognized by Fortune in 2020 as one of the World's 25 Greatest Leaders: Heroes of the Pandemic.
15.
In 2021, George Yancopoulos won the Roy Vagelos Humanitarian Award for REGEN-COV, Prix Galien Foundation and the New York Intellectual Property Law Association's Inventors of the Year for REGEN-COV.
16.
George Yancopoulos serves on a number of Boards, including on Regeneron's Board of Directors.
17.
George Yancopoulos currently serves on the Columbia University Medical Center Board of Visitors, as Vice Chair starting in 2012; the Board of Trustees for Cold Spring Harbor Laboratory, since 2015; the Scientific Advisory Council, Alliance on Cancer Gene Therapy, since 2007; the Scleroderma Research Foundation, Scientific Advisory Board, starting in 2004; and the Pershing Square Cancer Research Alliance, Advisory Board, since 2018.